{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:15:29Z","timestamp":1790691329428,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Pediatric Surgery"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.sempedsurg.2019.150859","type":"journal-article","created":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T08:01:55Z","timestamp":1574236915000},"page":"150859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["MIBG in neuroblastoma diagnosis and treatment"],"prefix":"10.1016","volume":"28","author":[{"given":"Elizabeth","family":"Olecki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa N","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9579","key":"10.1016\/j.sempedsurg.2019.150859_bib0001","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(07)60983-0","article-title":"Neuroblastoma","volume":"369","author":"Maris","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.sempedsurg.2019.150859_bib0002","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.hoc.2009.11.011","article-title":"Neuroblastoma: biology, prognosis, and treatment","volume":"24","author":"Park","year":"2010","journal-title":"Hematol Oncol Clin North Am"},{"issue":"3","key":"10.1016\/j.sempedsurg.2019.150859_bib0003","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1053\/j.semnuclmed.2016.02.002","article-title":"131I-Metaiodobenzylguanidine theranostics in neuroblastoma: historical perspectives; practical applications","volume":"46","author":"Parisi","year":"2016","journal-title":"Semin Nucl Med"},{"issue":"2","key":"10.1016\/j.sempedsurg.2019.150859_bib0004","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2214\/ajr.143.2.373","article-title":"Localization of m-iodo(131I)benzylguanidine in neuroblastoma","volume":"143","author":"Hattner","year":"1984","journal-title":"AJR Am J Roentgenol"},{"issue":"Suppl 1","key":"10.1016\/j.sempedsurg.2019.150859_bib0005","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.nucmedbio.2008.05.002","article-title":"Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastoma","volume":"35","author":"DuBois","year":"2008","journal-title":"Nucl Med Biol"},{"issue":"6","key":"10.1016\/j.sempedsurg.2019.150859_bib0006","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1210\/jc.2009-2604","article-title":"123I-meta-iodobenzylguanidine scintigraphy for the detection of neuroblastoma and pheochromocytoma: results of a meta-analysis","volume":"95","author":"Jacobson","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.sempedsurg.2019.150859_bib0007","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1148\/rg.2016150099","article-title":"MIBG in neuroblastoma diagnostic imaging and therapy","volume":"36","author":"Sharp","year":"2016","journal-title":"Radiographics"},{"issue":"13","key":"10.1016\/j.sempedsurg.2019.150859_bib0008","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1200\/JCO.2003.09.122","article-title":"Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma","volume":"21","author":"Matthay","year":"2003","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.sempedsurg.2019.150859_bib0009","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/pbc.20777","article-title":"Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma","volume":"47","author":"Messina","year":"2006","journal-title":"Pediatr Blood Cancer"},{"issue":"19","key":"10.1016\/j.sempedsurg.2019.150859_bib0010","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1200\/JCO.2004.07.144","article-title":"Scintigraphic response by 123I-metaiodobenzylguanidine scan correlates with event-free survival in high-risk neuroblastoma","volume":"22","author":"Katzenstein","year":"2004","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.sempedsurg.2019.150859_bib0011","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1200\/JCO.2012.45.8794","article-title":"Iodine-123 metaiodobenzylguanidine scintigraphy scoring allows prediction of outcome in patients with stage 4 neuroblastoma: results of the Cologne interscore comparison study","volume":"31","author":"Decarolis","year":"2013","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.sempedsurg.2019.150859_bib0012","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2967\/jnumed.112.112334","article-title":"Semiquantitative MIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group","volume":"54","author":"Yanik","year":"2013","journal-title":"J Nucl Med"},{"issue":"11","key":"10.1016\/j.sempedsurg.2019.150859_bib0013","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.ejca.2008.03.013","article-title":"The prognostic impact of functional imaging with (123)I-mIBG in patients with stage 4 neuroblastoma >1 year of age on a high-risk treatment protocol: results of the German neuroblastoma trial NB97","volume":"44","author":"Schmidt","year":"2008","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.sempedsurg.2019.150859_bib0014","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s00259-018-4070-8","article-title":"Guidelines on nuclear medicine imaging in neuroblastoma","volume":"45","author":"Bar-Sever","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"10.1016\/j.sempedsurg.2019.150859_bib0015","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/sj.bjc.6605621","article-title":"Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) task force","volume":"102","author":"Matthay","year":"2010","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.sempedsurg.2019.150859_bib0016","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2214\/AJR.07.2107","article-title":"Added value of SPECT\/CT for correlation of MIBG scintigraphy and diagnostic CT in neuroblastoma and pheochromocytoma","volume":"190","author":"Rozovsky","year":"2008","journal-title":"AJR Am J Roentgenol."},{"issue":"1","key":"10.1016\/j.sempedsurg.2019.150859_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/RLU.0b013e3181feeb5e","article-title":"Comparison of diagnostic value of I-123 MIBG and high-dose I-131 MIBG scintigraphy including incremental value of SPECT\/CT over planar image in patients with malignant pheochromocytoma\/paraganglioma and neuroblastoma","volume":"36","author":"Fukuoka","year":"2011","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10.1016\/j.sempedsurg.2019.150859_bib0018","first-page":"21","article-title":"Comparison of [123I]MIBG and [131I]MIBG for imaging of neuroblastoma and other neural crest tumors","volume":"57","author":"Liu","year":"2013","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.sempedsurg.2019.150859_bib0019","first-page":"237","article-title":"Long-term results of [131I]metaiodobenzylguanidine treatment of refractory advanced neuroblastoma","volume":"35","author":"Hutchinson","year":"1991","journal-title":"J Nucl Biol Med"},{"issue":"3","key":"10.1016\/j.sempedsurg.2019.150859_bib0020","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/00000421-199206000-00009","article-title":"131-I-metaiodobenzylguanidine treatment in patients with refractory advanced neuroblastoma","volume":"15","author":"Hutchinson","year":"1992","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"10.1016\/j.sempedsurg.2019.150859_bib0021","first-page":"244","article-title":"Efficacy and safety of [131I]metaiodobenzylguanidine therapy for patients with refractory neuroblastoma","volume":"35","author":"Matthay","year":"1991","journal-title":"J Nucl Biol Med"},{"issue":"9","key":"10.1016\/j.sempedsurg.2019.150859_bib0022","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1200\/JCO.2006.09.3484","article-title":"Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma","volume":"25","author":"Matthay","year":"2007","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.sempedsurg.2019.150859_bib0023","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1200\/JCO.1998.16.1.229","article-title":"Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma","volume":"16","author":"Matthay","year":"1998","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.sempedsurg.2019.150859_bib0024","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1200\/JCO.1992.10.12.1889","article-title":"Phase I\/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: a United Kingdom Children's Cancer Study Group investigation","volume":"10","author":"Lashford","year":"1992","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.sempedsurg.2019.150859_bib0025","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1200\/JCO.2007.15.7628","article-title":"Iodine-131\u2013metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I study","volume":"27","author":"Matthay","year":"2009","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.sempedsurg.2019.150859_bib0026","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/pbc.20240","article-title":"Tumor response and toxicity with multiple infusions of high dose 131I-MIBG for refractory neuroblastoma","volume":"44","author":"Howard","year":"2005","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"10.1016\/j.sempedsurg.2019.150859_bib0027","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/pbc.23062","article-title":"Safety and efficacy of tandem 131I-metaiodobenzylguanidine infusions in relapsed\/refractory neuroblastoma","volume":"57","author":"Johnson","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"1\u20132","key":"10.1016\/j.sempedsurg.2019.150859_bib0028","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1023\/A:1005770405844","article-title":"Optimal use of the 131-I-metaiodobenzylguanidine and cisplatin combination in advanced neuroblastoma","volume":"31","author":"Mastrangelo","year":"1997","journal-title":"J Neurooncol"},{"issue":"4 Suppl 1","key":"10.1016\/j.sempedsurg.2019.150859_bib0029","first-page":"69","article-title":"Treatment with meta-[131I]iodobenzylguanidine and cisplatin in stage IV neuroblastoma","volume":"39","author":"Mastrangelo","year":"1995","journal-title":"Q J Nucl Med"},{"issue":"4","key":"10.1016\/j.sempedsurg.2019.150859_bib0030","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1054\/bjoc.2000.1645","article-title":"Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy","volume":"84","author":"Mastrangelo","year":"2001","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.sempedsurg.2019.150859_bib0031","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/cbr.2005.20.195","article-title":"Feasibility of dosimetry-based high-dose 131I-meta-iodobenzylguanidine with topotecan as a radiosensitizer in children with metastatic neuroblastoma","volume":"20","author":"Gaze","year":"2005","journal-title":"Cancer Biother Radiopharm"},{"issue":"2","key":"10.1016\/j.sempedsurg.2019.150859_bib0032","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0959-8049(94)E0036-4","article-title":"Multi-modality megatherapy with [131I]meta-iodobenzylguanidine, high dose melphalan and total body irradiation with bone marrow rescue: feasibility study of a new strategy for advanced neuroblastoma","volume":"31A","author":"Gaze","year":"1995","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.sempedsurg.2019.150859_bib0033","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1200\/JCO.2005.03.6400","article-title":"Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study","volume":"24","author":"Matthay","year":"2006","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.sempedsurg.2019.150859_bib0034","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbmt.2014.12.008","article-title":"131I-metaiodobenzylguanidine with intensive chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma. A new approaches to neuroblastoma therapy (NANT) phase II study","volume":"21","author":"Yanik","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.sempedsurg.2019.150859_bib0035","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1007\/s00259-013-2510-z","article-title":"Toxicity of upfront \u00b9\u00b3\u00b9I-metaiodobenzylguanidine (\u00b9\u00b3\u00b9I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysis","volume":"40","author":"Bleeker","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"10.1016\/j.sempedsurg.2019.150859_bib0036","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/pbc.22986","article-title":"Treatment of advanced neuroblastoma in children over 1 year of age: the critical role of \u00b9\u00b3\u00b9I-metaiodobenzylguanidine combined with chemotherapy in a rapid induction regimen","volume":"56","author":"Mastrangelo","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"10.1016\/j.sempedsurg.2019.150859_bib0037","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/pbc.25580","article-title":"Upfront treatment of high-risk neuroblastoma with a combination of 131I-MIBG and topotecan","volume":"62","author":"Kraal","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.sempedsurg.2019.150859_bib0038","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ejca.2008.01.010","article-title":"Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age","volume":"44","author":"de Kraker","year":"2008","journal-title":"Eur J Cancer"}],"container-title":["Seminars in Pediatric Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055858619301179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055858619301179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T07:25:43Z","timestamp":1578468343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055858619301179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S1055858619301179"],"URL":"https:\/\/doi.org\/10.1016\/j.sempedsurg.2019.150859","relation":{},"ISSN":["1055-8586"],"issn-type":[{"value":"1055-8586","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MIBG in neuroblastoma diagnosis and treatment","name":"articletitle","label":"Article Title"},{"value":"Seminars in Pediatric Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sempedsurg.2019.150859","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"150859"}}